WHO Approves First Universal Flu Vaccine for Global Distribution

The World Health Organization has granted emergency approval to the world's first universal influenza vaccine, which provides broad protection against all known strains of the flu virus.

Developed by a consortium of pharmaceutical companies, the vaccine targets a conserved region of the influenza virus that rarely mutates, eliminating the need for annual reformulation. Clinical trials showed 85% efficacy across all tested flu strains.

Global distribution is expected to begin within six months, with priority given to healthcare workers and vulnerable populations in developing nations.